Find Academic Supervisors

Hao WuView profile

Associate Professor

• Epigenomics
• DNA methylation and demethylation
• Transcriptional control
• +4 more

Hao Wu, PhD is an Associate Professor of Genetics at the University of Pennsylvania's Perelman School of Medicine. He is a Core member of the Penn Epigenetics Institute, Member of the Penn Cardiovascular Institute (CVI), Member of the Penn Institute of Regenerative Medicine (IRM), and Member of the CHOP Center for Mitochondrial and Epigenomic Medicine (CMEM). His educational background includes: B.S. in Biological Sciences and Biotechnology from Tsinghua University (2002) Ph.D. in Epigenetic regulation of neural stem cell differentiation from University of California Los Angeles (2009) Dr. Wu's research focuses on understanding how epigenetic processes regulate gene expression to establish diverse cell types and respond to environmental signals. His lab combines experimental approaches with bioinformatics to study cell-type specification and maturation from mammalian stem cells, particularly in cardiovascular and neural lineages. The Wu lab investigates molecular mechanisms regulating the interaction between environment and epigenome, and how extrinsic signals modify epigenetic marks to influence development or disease. Their long-term goal is to quantitatively analyze and engineer cell-type specific epigenomes to inform therapeutic approaches for human diseases. Analysis of Dr. Wu's recent publications reveals a strong focus on single-cell and spatial multiomic technologies to investigate epigenetic regulation. His work spans cardiovascular biology, neuroscience, and stem cell biology, with emphasis on DNA methylation/demethylation, transcriptional control, and development of novel genomic sequencing methods. Recent publications highlight advances in single-cell epigenomic profiling, time-resolved RNA sequencing, and their application to neural development, cardiac maturation, and disease mechanisms. As a mentor, Dr. Wu oversees a diverse research group including postdoctoral fellows, graduate students, research specialists, and undergraduates. His lab members work on various projects related to epigenomic profiling, epigenome editing, and single-cell technologies. Dr. Wu's research is supported by grants enabling the development of innovative genomic technologies and their application to understand fundamental biological processes. The Wu Lab maintains a collaborative environment focused on developing high-precision single-cell epigenomic profiling methods, novel epigenome editing tools, and time-resolved single-cell RNA sequencing approaches. Current projects investigate neural development, cardiac lineage specification, and the environment-epigenome interaction, bridging fundamental epigenetic mechanisms with translational applications.

• Tuberculosis
• Respiratory Medicine
• Epidemiology
• +3 more

Dr. Vernon Hoeppner serves as Professor in the Division of Respirology, Critical Care and Sleep Medicine at the University of Saskatchewan, where he pioneered North America's first Directly Observed Therapy (DOT) program for tuberculosis treatment. His career spans clinical practice, provincial TB program leadership, and research focused on health equity among Indigenous populations in Saskatchewan and the Canadian prairies, emphasizing that "therapy is only as good as relationships and trust with patients and communities." His research interests center on Tuberculosis epidemiology , Respiratory medicine , and Health disparities , with particular focus on Indigenous health outcomes, treatment adherence, and social determinants of disease. Hoeppner's work integrates clinical practice with public health strategy, examining TB transmission dynamics, cost-effectiveness of interventions, and genomic epidemiology of Mycobacterium tuberculosis strains. Analysis of his 2014-2025 publications reveals evolving research trajectories: early work concentrated on TB transmission in Indigenous communities and treatment protocols, while recent studies expanded into genomic epidemiology (2024), health economics of latent TB treatment (2020), and climate-disease interactions in pandemic modeling (2025). His scholarship consistently addresses health inequities through both quantitative epidemiological methods and qualitative patient-centered approaches.

John ScrenockView profile

Tutor

• Hebrew Bible
• Psalms
• Dead Sea Scrolls
• +4 more

John Screnock is a Tutor in Old Testament/Hebrew Bible at Wycliffe Hall, University of Oxford (since 2021). He previously served as a Research Fellow in Hebrew Bible (2018-2021) and Kennicott Fellow in Hebrew (2015-2018) at Oxford. Education: PhD from University of Toronto His research spans Hebrew Bible , Psalms , Dead Sea Scrolls , Septuagint , and ancient Hebrew linguistics , focusing on scribal practices, textual criticism, and interlingual translation dynamics. Recent publications emphasize manuscript evidence from Qumran, Ugaritic parallels, and poetics in biblical Hebrew. Key article trends include: Textual criticism methodologies across Hebrew, Septuagint, and Dead Sea Scrolls Scribal activity in Psalms and Exodus Numeral syntax and linguistic peculiarities in ancient Hebrew Comparative analysis of command-execution structures in biblical literature Contact: john.screnock@wycliffe.ox.ac.uk

• Human Factors Engineering
• Medical Image Perception
• Perceptual Errors
• +5 more

William F. Auffermann is a Professor at the Department of Radiology and Imaging Sciences, University of Utah, with a dual board certification in Diagnostic Radiology and Clinical Informatics. He serves as Vice Chair for IT and Informatics and Section Chief for Cardiothoracic Imaging, focusing on improving informatics systems and medical education through simulation-based tools. Education: MD and PhD from University of Minnesota Medical School, Fellowship in Cardiothoracic Imaging at Duke University. Board Certifications: American Board of Radiology (Diagnostic Radiology), American Board of Preventive Medicine (Clinical Informatics). His research centers on human factors engineering , integrating medical image perception studies with computer simulation-based education to reduce diagnostic errors. Key areas include biomedical informatics , machine learning , structured reporting , and clinical decision support . Collaborative work spans chest and cardiac imaging with applications in occupational lung disease (NIOSH B-Reader certification). Recent publications emphasize AI integration in radiology , perceptual training , and gaze-display feedback for medical education. He also contributed to ACR Appropriateness Criteria for thoracic imaging and led studies on virtual reality education and gamification in radiology training .

Alejandro OchoaView profile

Assistant Professor

• Statistical Genetics
• Computational Biology
• Population Genetics
• +3 more

Alejandro Ochoa is an Assistant Professor of Biostatistics & Bioinformatics at Duke University , affiliated with the Duke Center for Statistical Genetics and Genomics , Duke Institute for Brain Sciences , and the Center for Combinatorial Gene Regulation . His research focuses on statistical genetics and computational biology , addressing challenges in population structure estimation, genetic association models, and heritability analysis with applications to multi-ethnic studies and admixed populations . Education : Ph.D. in Quantitative and Computational Biology from Princeton University (2013) Research Highlights : Develops scalable statistical methods for genetic studies under arbitrary relatedness, emphasizing equity in multi-ethnic cohorts . Key contributions include software packages like popkin (kinship estimation), ligera (robust association studies), and bnpsd (admixed population simulation). His work addresses biases in principal component analysis , heritability estimation , and GWAS meta-analysis . Grants : National Institutes of Health (2023-2026): Regulators of Calcineurin Pathways as Diagnostic and Therapeutic Targets for Nephrotic Syndrome National Institutes of Health (2020-2026): HLA Risk Alleles in Primary Nephrotic Syndrome National Human Genome Research Institute (2020-2025): Duke FUNCTION Center Labs & Collaborations : Leads the Ochoa Lab , which develops open-source software under GNU General Public License and collaborates with programs like UPGG and CBB .

• Ophthalmic Pathology
• Surgical Pathology
• Tear Biochemistry
• +4 more

Ben J. Glasgow, MD is a Professor of Pathology and Laboratory Medicine at the University of California, Los Angeles (UCLA). He serves as Chief of Ophthalmic Pathology and is affiliated with the Jules Stein Eye Institute and the ACCESS Program within the Department of Cellular & Molecular Pathology. His clinical expertise spans Ophthalmic Pathology and Surgical Pathology, with a focus on ocular surface diseases and corneal disorders. Education: MD from Johns Hopkins University School of Medicine (1979), followed by an Internal Medicine internship at UCSD Medical Center (1980), Anatomic & Clinical Pathology residency at UCLA (1988), Ophthalmology residency at UCLA (1991), and a fellowship in Ophthalmic Pathology at UCLA (1987). Certifications: Board-certified in Pathology-Clinical (1988) and Pathology-Anatomic (1987) by the American Board of Pathology. Affiliation: Practices at Ronald Reagan UCLA Medical Center (Los Angeles, CA 90095). Dr. Glasgow's research centers on tear biochemistry, particularly the structural and functional properties of tear lipocalin. His work explores lipid-protein interactions in tear film, corneal dystrophies, and ocular surface pathologies. He has contributed extensively to understanding tear film composition and its role in ocular health through 15 recent publications (2025-2021) covering topics such as: Lipocalin-ligand binding mechanisms Orbital tumor pathology and sarcomas Tear film lipid analysis Corneal dystrophy genetics Post-surgical complications like calcium deposition Novel ophthalmic device evaluations His scholarly output demonstrates a consistent focus on molecular ophthalmic pathology, lipid biochemistry, and advanced diagnostic techniques using fluorescence microscopy and polarization imaging. All publications are indexed in PubMed, reflecting his commitment to evidence-based ophthalmic research.

Stephanie WhiteView profile

Professor

• Vocal Learning
• Social Neuroscience
• Behavioral Genetics
• +5 more

Stephanie White , a Professor in the Department of Integrative Biology & Physiology at the College of Life Sciences , University of California, Los Angeles, investigates the interplay between social behaviors and neuronal plasticity in zebra finches . Her research focuses on how vocal learning—a critical reproductive behavior—is shaped by gene expression and neural circuitry, particularly through comparative studies of sexually dimorphic brain structures. Her recent publications highlight diverse research directions, from genomic analyses of domestication syndrome in songbirds to RNA diagnostics and clinical implications in neurodevelopmental disorders . Collaborative studies include FOXP2 transcriptional targets and microRNA regulation in vocal learning . Stephanie’s lab employs behavioral experiments , electrophysiology , and molecular techniques to explore how social interactions modulate gene expression and neural properties. She also contributes to interdisciplinary discussions on genetics in palliative care and terminology standardization in genomics . Contact: sawhite@ucla.edu | Lab Website

Hume Akahori StroudView profile

Assistant Professor

• Epigenetic gene regulation
• Transposon silencing
• Transcriptional programs
• +6 more

Hume Akahori Stroud is an Assistant Professor in the Department of Neuroscience at UT Southwestern Medical Center . He earned his B.A. from Cornell University and completed his Ph.D. at the University of California, Los Angeles, working on plant transposon regulation under Dr. Steven E. Jacobsen . His postdoctoral research at Harvard Medical School with Dr. Michael E. Greenberg focused on neuronal development. Education B.A., Cornell University Ph.D., University of California, Los Angeles Postdoctoral Research, Harvard Medical School The Stroud Lab investigates epigenetic gene regulation mechanisms in health and disease, particularly in neurological disorders and cancer . His research bridges plant epigenetics and mammalian neuronal epigenetics, focusing on DNA methylation, histone variants, and chromatin remodeling. His recent publications highlight studies on MeCP2 function in neuronal enhancers , microRNA-29 in brain maturation , and transcriptional transitions in postnatal neurons . Earlier work includes plant epigenetics, such as transposon silencing and histone variant roles in DNA methylation . Current projects in the lab explore how epigenetic disruptions affect neural circuits and contribute to disease, leveraging advanced genomic tools to map activity-dependent regulatory elements and develop cell-type-specific viral vectors.

Jing SunView profile

Academic

• Epidemiology
• HIV/AIDS
• Biomarkers
• +6 more

Jing Sun, MD, PhD, MPH is an Associate Research Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. Her primary departmental affiliation is with the Infectious Disease Epidemiology division, and she holds significant center affiliations including the Johns Hopkins Center for AIDS Research (CFAR) and the AIDS Linked To the Intravenous Experience (ALIVE) cohort study. She is also involved with the MACS/WIHS Combined Cohort Study and contributes to the National COVID Cohort Collaborative (N3C). Dr. Sun earned her MD from Guangdong Medical University (2008), MPH from the University of Wisconsin (2011), and PhD from Drexel University (2015). Her educational background spans clinical medicine, public health, and epidemiological research methods. As a molecular epidemiologist specializing in HIV and aging, Dr. Sun's research focuses on molecular factors impacting long-term health outcomes of people living with chronic infections, particularly HIV and viral hepatitis. Her work centers on investigating age-related biomarkers, especially mitochondrial function, on multi-organ aging among people living with HIV. She also examines the impact of viral hepatitis and HIV coinfections on liver disease progression. During the COVID-19 pandemic, her research with the N3C addressed risk of severe outcomes and vaccine effectiveness among immunocompromised populations, with findings cited by the CDC in vaccine prioritization decisions. Her extensive publication record (55+ publications) demonstrates consistent research productivity, with recent work spanning HIV and aging, injection drug use epidemiology, social determinants of health, and the intersection of HIV with emerging infectious diseases like COVID-19. Her research employs diverse methodologies including molecular epidemiology, cohort studies, computational phenotyping, and machine learning approaches to identify risk factors and health disparities. Dr. Sun has received numerous prestigious awards including the CFAR Scholar Faculty Development Award (2019), Cooper Scholar designation (2018), New Investigator Scholarship at CROI (2018), and multiple travel and mentoring awards supporting her work in HIV and aging research. Her collaborative research involves significant work with the ALIVE cohort (a longitudinal study of people who inject drugs in Baltimore), the MACS/WIHS Combined Cohort Study, and the National COVID Cohort Collaborative. She frequently collaborates with interdisciplinary teams spanning epidemiology, infectious diseases, biostatistics, and computational sciences to address complex questions in HIV epidemiology and aging.

• Clinical Psychology
• Neuroimaging
• Affective Neuroscience
• +7 more

Albert Wabnegger (Mag. Dr. rer. nat.) is a researcher at the Institute of Psychology , Faculty of Natural Sciences , University of Graz in Austria. His work is anchored in clinical psychology and affective neuroscience, with a strong emphasis on neuroimaging approaches that illuminate the neural underpinnings of emotion, phobia, and impulse-control disorders. Research Interests Neurobiological bases of disgust processing and its maladaptive variants (e.g., dental phobia, skin-picking disorder) Functional and structural brain alterations in anxiety and impulse-control disorders Placebo and nocebo effects on emotional distress and motor performance Social cognition, conspiracy beliefs, and their neural correlates Sex-specific neural responses to personal-space intrusion and affective touch Publication Trends Across more than 40 peer-reviewed articles (2012-2025), Wabnegger’s research demonstrates a clear trajectory from basic affective neuroscience toward translational clinical applications. Early work mapped structural brain differences in phobia and disgust propensity using voxel-based morphometry. Subsequent studies integrated fMRI to explore amygdala, cerebellar, and prefrontal contributions to emotion regulation, placebo effects, and aberrant social cognition. Recent mega-analyses within the ENIGMA consortium extend these findings to large-scale, cross-disorder investigations of brain aging and morphological alterations in youth psychopathology. Collaborations & Networks Active member of the Brain and Behavior research network at the University of Graz Contributor to the ENIGMA Anxiety working group, participating in international mega-analyses Ongoing interdisciplinary projects with clinical partners, integrating neuroimaging and behavioral interventions Contact Institute of Psychology, University of Graz Universitätsplatz 2/III, 8010 Graz, Austria Phone: +43 (0)316 380-5131 Email: albert.wabnegger@uni-graz.at

• Antibiotic Resistance
• Influenza Virus Research
• One Health Approach
• +3 more

Josef Järhult is a Professor at Uppsala University's Faculty of Medicine, holding dual appointments in the Department of Medical Sciences (Infectious Diseases) and as a Guest Researcher in the Department of Medical Biochemistry and Microbiology. His work spans multiple disciplines with a focus on the intersection of human, animal, and environmental health. At the Academic Hospital, he works in the Infection department (entrance 34, 1st floor), and at the university, he is based at BMC Husargatan 3 in Uppsala. Dr. Järhult's research program centers on antibiotic resistance mechanisms and transmission, particularly examining the environmental dimension of antimicrobial resistance. His work frequently employs the One Health framework, investigating connections between human medicine, veterinary science, and environmental factors. Key areas include the study of ESBL-producing bacteria in water systems, influenza virus transmission between species, and antimicrobial resistance patterns across different settings including hospitals, farms, and wildlife. His laboratory work often involves genomic analysis of resistant pathogens and examination of resistance gene transmission across human-animal-environment interfaces. Analysis of his recent publications reveals a strong emphasis on spatial and temporal patterns of antimicrobial resistance, with significant work conducted in Sweden and Southeast Asia. His research program demonstrates consistent productivity with publications spanning clinical infectious diseases, environmental microbiology, and translational research connecting laboratory findings to public health implications. The work often involves international collaborations across Europe, Southeast Asia, and North America. Dr. Järhult has contributed significantly to understanding how antimicrobial resistance develops and spreads in natural environments, particularly examining the role of water systems and wildlife as reservoirs and vectors for resistant bacteria. His work on influenza viruses in waterfowl has provided important insights into viral evolution and transmission dynamics between wild birds and domestic animals.

• Bioinformatics
• Computational Biology
• Genomics
• +3 more

Anton Nekrutenko is a Professor at the Huck Institutes of the Life Sciences , Pennsylvania State University, specializing in bioinformatics and computational biology. He leads development of the Galaxy platform , an open-source framework for reproducible genomic data analysis. Research Interests include: Genomic data analysis tools and workflows Evolutionary biology and phylogenetics Energy-efficient bioinformatics computing Open science and collaborative platforms Pathogen surveillance systems His recent work focuses on scalable genome assembly, protein interaction modeling, and pandemic response frameworks using open data. Projects emphasize biodiversity research, computational efficiency, and biomedical applications of next-generation sequencing. Scientific Awards and recognitions include: High citation index (45 h-index) in computational biology NSF funding for Galaxy platform development Leadership in global biodiversity genomics initiatives

• Ancient Egyptian funerary texts
• Transmission of funerary texts
• Cultural history of the Middle Kingdom

Louise Gestermann serves as Associate Professor at the University of Tübingen's Institute for Ancient Near Eastern Studies within the Faculty of Humanities, while maintaining her primary position as Extraordinary Professor at the University of Bonn. Her scholarly work focuses on Ancient Egyptian funerary traditions and Middle Kingdom socio-political structures. Her academic formation includes: Magister Artium in Göttingen (1981) PhD at University of Tübingen (1985) on Middle Kingdom administration Habilitation at University of Bonn (1997) on late-period Coffin Texts transmission Professor Gestermann's research centers on the evolution of Egyptian funerary literature, particularly the Coffin Texts and Book of the Dead, examining textual transmission across historical periods. Her work bridges philological analysis with archaeological context, revealing how funerary practices reflected societal changes during the Middle Kingdom's political transformations. She has made significant contributions to understanding scribal traditions and religious syncretism in ancient Egypt. Her recent publications demonstrate sustained focus on Theban tomb complexes, especially the Monthemhet tomb (TT 34) decoration program, while maintaining scholarly engagement with Middle Kingdom political history and funerary text variants. This dual concentration reveals connections between administrative structures and religious expression in pharaonic Egypt. Research funding includes a two-year Fritz Thyssen Foundation grant (2012-2014) for the Monthemhet tomb project and a Lower Saxony state PhD scholarship (1990). She has directed fieldwork components for German-Spanish-Egyptian missions in Thebes and participated in Kōm al-ahmar excavations. Professor Gestermann has contributed to major collaborative projects including the Adolf Erman estate processing at University of Bremen (2002-2006) and co-edited significant Egyptological reference works. Her interdisciplinary approach connects textual analysis with material culture studies across multiple excavation sites.

• Molecular Biology
• Biochemistry
• Virology
• +6 more

József Tőzsér is a Professor at the Institute of Biochemistry and Molecular Biology within the Medical School of the University of Debrecen. With an extensive publication record spanning from 1986 to 2025, he has established himself as a leading researcher in molecular biology and biochemistry, particularly in virology and protein science. Professor Tőzsér's research primarily focuses on molecular mechanisms of viral infections, protein structure and function, and enzyme kinetics. His work spans several key areas including HIV research, SARS-CoV-2 pathogenesis, proteomics, structural biology, and molecular mechanisms of disease. His laboratory has made significant contributions to understanding viral proteases, host-pathogen interactions, and protein networks in various disease states. Analysis of his recent publications (2023-2025) reveals a strong emphasis on viral research, particularly concerning SARS-CoV-2 and HIV. His work combines structural biology, proteomics, and molecular biology approaches to investigate viral entry mechanisms, protease functions, and host immune responses. The interdisciplinary nature of his research is evident in the diverse range of journals where his work appears, spanning biochemistry, virology, molecular biology, and clinical medicine. With 236 uploaded publications, including 220 in the DEA repository and 86 open access articles, Professor Tőzsér has built a substantial scholarly record. His work appears prominently in high-impact journals with Q1/D1 rankings in Biochemistry, Molecular Biology, Virology, and related fields. He has collaborated with numerous researchers, with notable co-authors including Berta Andras, Adrienne Czutak, Stephen Lion, and Irene T. Weber. Professor Tőzsér's research program demonstrates consistent productivity and relevance to contemporary biomedical challenges, particularly in viral pathogenesis and protein science. His work bridges basic molecular mechanisms with potential clinical applications, as evidenced by studies on antiviral therapies and disease biomarkers.

Nathaniel HathawayView profile

Assistant Professor

• Epigenetics
• Chemical Biology
• Gene Expression
• +3 more

Nathaniel Hathaway , PhD, is an Assistant Professor at the Eshelman School of Pharmacy , UNC-Chapel Hill, and a member of the UNC Lineberger Comprehensive Cancer Center. His research bridges chemical biology and epigenetics to unravel molecular mechanisms governing gene expression , with a focus on chromatin dynamics and heterochromatin formation . Education: Undergraduate degree magna cum laude (2001), Michelson-Morley Research Competition winner (2000). Hathaway's lab pioneers chemical epigenetic modifiers (CEMs) that harness endogenous chromatin machinery via dCas9 targeting to regulate gene expression. His work also involves high-throughput drug discovery for epigenetic inhibitors in cancer and other diseases. Recent publications highlight CRISPR-CEM fusion systems , PROTAC-based PRC2 degradation , and computational models of heterochromatin . Key awards: CBMC Teaching Recognition (2016, 2017) IBM Junior Faculty Development Award (2017) AACP New Investigator Award (2016) Hathaway's research integrates protein bioengineering , synthetic chemistry , and mammalian models to address fundamental questions in epigenetic memory and develop translational therapies for cancer.